ConductScience.org, home
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
API referenceFor AI assistants

Trial · NCT02432274

Adverse events4,158

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 4,158

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersLenvatinib 5 mg/m^2020
otherAnaemiaBlood and lymphatic system disordersCohort 1, Single-agent Dose-finding: Lenvatinib 11 mg/m^2152
otherAnaemiaBlood and lymphatic system disordersCohort 1, Single-agent Dose-finding: Lenvatinib 14 mg/m^22112
otherAnaemiaBlood and lymphatic system disordersCohort 1, Single-agent Dose-finding: Lenvatinib 17 mg/m^2171
otherAnaemiaBlood and lymphatic system disordersCohort 2A, Single-agent Expansion, DTC: Lenvatinib 14 mg/m^2010
otherAnaemiaBlood and lymphatic system disordersCohort2B,Single-agentExpansion,Osteosarcoma:Lenvatinib14mg/m^25317
otherAnaemiaBlood and lymphatic system disordersCohort 3A, Combination Dose-finding: Lenvatinib 11 mg/m^291143
otherAnaemiaBlood and lymphatic system disordersCohort 3A, Combination Dose-finding: Lenvatinib 14 mg/m^271129
otherAnaemiaBlood and lymphatic system disordersCohort 3B, Combination Expansion: Lenvatinib 14 mg/m^2152077
otherLymphopeniaBlood and lymphatic system disordersLenvatinib 5 mg/m^2020
otherLymphopeniaBlood and lymphatic system disordersCohort 1, Single-agent Dose-finding: Lenvatinib 11 mg/m^2050
otherLymphopeniaBlood and lymphatic system disordersCohort 1, Single-agent Dose-finding: Lenvatinib 14 mg/m^20110
otherLymphopeniaBlood and lymphatic system disordersCohort 1, Single-agent Dose-finding: Lenvatinib 17 mg/m^2174
otherLymphopeniaBlood and lymphatic system disordersCohort 2A, Single-agent Expansion, DTC: Lenvatinib 14 mg/m^2010
otherLymphopeniaBlood and lymphatic system disordersCohort2B,Single-agentExpansion,Osteosarcoma:Lenvatinib14mg/m^20310
otherLymphopeniaBlood and lymphatic system disordersCohort 3A, Combination Dose-finding: Lenvatinib 11 mg/m^22118
otherLymphopeniaBlood and lymphatic system disordersCohort 3A, Combination Dose-finding: Lenvatinib 14 mg/m^20110
otherLymphopeniaBlood and lymphatic system disordersCohort 3B, Combination Expansion: Lenvatinib 14 mg/m^22203
otherNeutropeniaBlood and lymphatic system disordersLenvatinib 5 mg/m^2020
otherNeutropeniaBlood and lymphatic system disordersCohort 1, Single-agent Dose-finding: Lenvatinib 11 mg/m^2151

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02432274/events

API referenceFor AI assistants